Catalyst Wire Dossier Catalyst Wire Dossier

SNA-120

· Sienna Biopharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SNA-120, covering 2019-02-08 to 2019-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris [Phase 2]

See pricing